Pfizer generated free cash flow of $10.4 billion in the 12 months ending Sept. 30, 2025. During this period, the pharma giant ...

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

US IPOs delivered underwhelming results in 2025 as equity-market volatility and increasing scrutiny around themes such as ...

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

The Pharmacy Board has warned of falsified IBRANCE breast cancer drugs after a WHO alert, urging vigilance to protect patients.

The fraudulent products claim to be made by Pfizer, a major pharmaceutical company, but tests show they are completely fake.

Major pharmaceutical companies are pushing ahead with sweeping price increases on hundreds of medicines in the United States, ...

With activist investors gone and revenue stabilizing, the undervalued pharmaceutical giant offers a compelling chance for ...

Consumers must be proactive in asking about eligibility to avoid bills that could exceed $1,000 for a five-day supply, ...

Pfizer has received a tax demand order amounting to Rs 8.79 crore, including penalty, from the Office of the Additional ...

The cost of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the ...